Tatva Chintan Pharma Chem has informed that the meeting of the Board of Directors of the Company is scheduled on 17/07/2026 to consider and approve and take on record the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30 June 2026. Further, in accordance with the Company's Code of Conduct for Prohibition of Insider Trading, the Company has intimated its 'designated persons' regarding the closure of the Trading Window for trading in the Company's equity shares from 01 July 2026 till the expiry of 48 hours from the date the said financial results are made public.
The above information is a part of company’s filings submitted to BSE.
